UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome

International journal of molecular sciences, 2016-03, Vol.17 (3), p.367-367

2016

Volltextzugriff (PDF)

Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease

Arteriosclerosis, thrombosis, and vascular biology, 2014-06, Vol.34 (6), p.1155-1161

2014

Volltextzugriff (PDF)

The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease

Clinical and Molecular Hepatology, 2021, 27(1), , pp.22-43

2021

Volltextzugriff (PDF)

Circulating Markers of Liver Function and Cardiovascular Disease Risk

Arteriosclerosis, thrombosis, and vascular biology, 2015-11, Vol.35 (11), p.2290-2296

2015

Volltextzugriff (PDF)

Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial

PloS one, 2016-12, Vol.11 (12), p.e0168216-e0168216

2016

Volltextzugriff (PDF)

Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes

PloS one, 2013-02, Vol.8 (2), p.e57183-e57183

2013

Volltextzugriff (PDF)

Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study

PloS one, 2019-01, Vol.14 (1), p.e0208736-e0208736

2019

Volltextzugriff (PDF)

Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD)

Current pharmaceutical design, 2020, Vol.26 (10), p.1079-1092

2020

Volltextzugriff (PDF)

Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring

BMC genomics, 2009-10, Vol.10 (1), p.478-478

2009

Volltextzugriff (PDF)

Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis

PloS one, 2024-04, Vol.19 (4), p.e0299507-e0299507

2024

Volltextzugriff (PDF)

History of Gestational Diabetes and Incident Nonalcoholic Fatty Liver Disease: The Kangbuk Samsung Health Study

The American journal of gastroenterology, 2023-11, Vol.118 (11), p.1980-1988

2023

Volltextzugriff (PDF)

Heterogeneity of white adipocytes in metabolic disease

Current opinion in clinical nutrition and metabolic care, 2023-03, Vol.26 (2), p.72-77

2023

Volltextzugriff (PDF)

Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention

Cardiovascular diabetology, 2022-12, Vol.21 (1), p.270-270, Article 270

2022

Volltextzugriff (PDF)

Systematic review with meta‐analysis: non‐alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density

Alimentary pharmacology & therapeutics, 2019-02, Vol.49 (4), p.375-388

2019

Volltextzugriff (PDF)

Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study

Arteriosclerosis, thrombosis, and vascular biology, 2023-03, Vol.43 (3), p.482-491

2023

Volltextzugriff (PDF)

Pelvic Exenteration for Squamous Cell Carcinoma of the Anus: Oncological, Morbidity, and Quality of Life Outcomes

Diseases of the colon & rectum, 2023-11

2023

Volltextzugriff (PDF)

Association of Plasma Ceramides With Myocardial Perfusion in Patients With Coronary Artery Disease Undergoing Stress Myocardial Perfusion Scintigraphy

Arteriosclerosis, thrombosis, and vascular biology, 2018-12, Vol.38 (12), p.2854-2861

2018

Volltextzugriff (PDF)

Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future

Clinical and Molecular Hepatology, 2023, 29(0), , pp.157-170

2023

Volltextzugriff (PDF)

Update on cardiovascular risk in nonalcoholic fatty liver disease

Current opinion in cardiology, 2021-07, Vol.36 (4), p.478-486

2021

Volltextzugriff (PDF)

Editorial: Recent advances in fibrosis assessment for metabolic dysfunction‐associated fatty liver disease–Authors' reply

Alimentary pharmacology & therapeutics, 2023-09, Vol.58 (6), p.638-639

2023

Volltextzugriff (PDF)

What determines perceived graduate employability? Exploring the effects of personal characteristics, academic achievements and graduate skills in a survey experiment

Studies in higher education (Dorchester-on-Thames), 2022-01, Vol.47 (1), p.159-176

Byrne, Christopher

2022

Volltextzugriff (PDF)

Gallstone Disease and Increased Risk of Ischemic Heart Disease: Causal Association or Epiphenomenon?

Arteriosclerosis, thrombosis, and vascular biology, 2015-10, Vol.35 (10), p.2073-2075

2015

Volltextzugriff (PDF)

Drug network identification predicts injecting risk behavior among people who inject drugs on hepatitis C virus treatment in Tayside, Scotland

Behavioral medicine (Washington, D.C.), 2024-04, Vol.50 (2), p.130-140

2024

Volltextzugriff (PDF)

Secondary bile acids improve risk prediction for non‐invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease

Alimentary pharmacology & therapeutics, 2023-04, Vol.57 (8), p.872-885

2023

Volltextzugriff (PDF)

Letter: Drug interaction in resmetirom times

Alimentary pharmacology & therapeutics, 2024-08, Vol.60 (4), p.533-534

2024

Volltextzugriff (PDF)

1 – 25 von 234

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(231)
Mit Volltextzugriff
(193)

Publikationsform

Artikel
(233)
Berichte
(1)

Sprache

Englisch
(234)

Erscheinungsjahr

n.n

Thema

Science & Technology
(178)
Life Sciences & Biomedicine
(146)
Humans
(108)
Male
(64)
Female
(57)
Adult
(39)
Middle Aged
(36)
Gastroenterology & Hepatology
(30)
Risk Factors
(30)
Animals
(29)
Aged
(26)
Surgery
(25)
Science & Technology - Other Topics
(23)
Biological And Medical Sciences
(22)
Multidisciplinary Sciences
(22)
Cardiovascular System & Cardiology
(20)
Medical Sciences
(18)
Social Sciences
(18)
Treatment Outcome
(18)
Aged, 80 And Over
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome

Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease

The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease

Circulating Markers of Liver Function and Cardiovascular Disease Risk

Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial

Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes

Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study

Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD)

Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring

Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis

History of Gestational Diabetes and Incident Nonalcoholic Fatty Liver Disease: The Kangbuk Samsung Health Study

Heterogeneity of white adipocytes in metabolic disease

Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention

Systematic review with meta‐analysis: non‐alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density

Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study

Pelvic Exenteration for Squamous Cell Carcinoma of the Anus: Oncological, Morbidity, and Quality of Life Outcomes

Association of Plasma Ceramides With Myocardial Perfusion in Patients With Coronary Artery Disease Undergoing Stress Myocardial Perfusion Scintigraphy

Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future

Update on cardiovascular risk in nonalcoholic fatty liver disease

Editorial: Recent advances in fibrosis assessment for metabolic dysfunction‐associated fatty liver disease–Authors' reply

What determines perceived graduate employability? Exploring the effects of personal characteristics, academic achievements and graduate skills in a survey experiment

Gallstone Disease and Increased Risk of Ischemic Heart Disease: Causal Association or Epiphenomenon?

Drug network identification predicts injecting risk behavior among people who inject drugs on hepatitis C virus treatment in Tayside, Scotland

Secondary bile acids improve risk prediction for non‐invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease

Letter: Drug interaction in resmetirom times

Aktive Filter

Suchergebnisse filtern